These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 33645171)

  • 1. Clinical usefulness of drug-laboratory test interaction alerts: a multicentre survey.
    van Balveren JA; Verboeket-van de Venne WPHG; Doggen CJM; Cornelissen AS; Erdem-Eraslan L; de Graaf AJ; Krabbe JG; Musson REA; Oosterhuis WP; de Rijke YB; van der Sijs H; Tintu AN; Verheul RJ; Hoedemakers RMJ; Kusters R; ;
    Clin Chem Lab Med; 2021 Jun; 59(7):1239-1245. PubMed ID: 33645171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time monitoring of drug laboratory test interactions: a proof of concept.
    van Balveren JA; Verboeket-van de Venne WPHG; Doggen CJM; Erdem-Eraslan L; de Graaf AJ; Krabbe JG; Musson REA; Oosterhuis WP; de Rijke YB; van der Sijs H; Tintu AN; Verheul RJ; Hoedemakers RMJ; Kusters R
    Clin Chem Lab Med; 2022 Jan; 60(2):235-242. PubMed ID: 34751523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic error as a result of drug-laboratory test interactions.
    van Balveren JA; Verboeket-van de Venne WPHG; Erdem-Eraslan L; de Graaf AJ; Loot AE; Musson REA; Oosterhuis WP; Schuijt MP; van der Sijs H; Verheul RJ; de Wolf HK; Kusters R; Hoedemakers RMJ;
    Diagnosis (Berl); 2019 Mar; 6(1):69-71. PubMed ID: 30753158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of interactions between drugs and laboratory test results on diagnostic test interpretation - a systematic review.
    van Balveren JA; Verboeket-van de Venne WPHG; Erdem-Eraslan L; de Graaf AJ; Loot AE; Musson REA; Oosterhuis WP; Schuijt MP; van der Sijs H; Verheul RJ; de Wolf HK; Kusters R; Hoedemakers RMJ;
    Clin Chem Lab Med; 2018 Nov; 56(12):2004-2009. PubMed ID: 30332390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FDA-approved drugs that interfere with laboratory tests: A systematic search of US drug labels.
    Yao H; Rayburn ER; Shi Q; Gao L; Hu W; Li H
    Crit Rev Clin Lab Sci; 2017 Jan; 54(1):1-17. PubMed ID: 27193822
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Added value of drug-laboratory test interaction alerts in test result authorisation.
    van Balveren JA; Verboeket-van de Venne WPHG; Doggen CJM; Erdem-Eraslan L; de Graaf AJ; Krabbe JG; Musson REA; Oosterhuis WP; de Rijke YB; van der Sijs H; Tintu AN; Verheul RJ; Hoedemakers RMJ; Kusters R
    Clin Chem Lab Med; 2022 Apr; 60(5):e108-e111. PubMed ID: 35184434
    [No Abstract]   [Full Text] [Related]  

  • 7. Do user preferences align with human factors assessment scores of drug-drug interaction alerts?
    Lowenstein D; Zheng WY; Burke R; Kenny E; Sandhu A; Makeham M; Westbrook J; Day RO; Baysari MT
    Health Informatics J; 2020 Mar; 26(1):563-575. PubMed ID: 30973280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug interference with biochemical laboratory tests.
    Katanić J; Stanimirov B; Sekeruš V; Đanić M; Pavlović N; Mikov M; Stankov K
    Biochem Med (Zagreb); 2023 Jun; 33(2):020601. PubMed ID: 37143715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overall performance of a drug-drug interaction clinical decision support system: quantitative evaluation and end-user survey.
    Van De Sijpe G; Quintens C; Walgraeve K; Van Laer E; Penny J; De Vlieger G; Schrijvers R; De Munter P; Foulon V; Casteels M; Van der Linden L; Spriet I
    BMC Med Inform Decis Mak; 2022 Feb; 22(1):48. PubMed ID: 35193547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A survey of nursing home physicians to determine laboratory monitoring adverse drug event alert preferences.
    Boyce RD; Perera S; Nace DA; Culley CM; Handler SM
    Appl Clin Inform; 2014; 5(4):895-906. PubMed ID: 25589905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electronic drug interaction alerts in ambulatory care: the value and acceptance of high-value alerts in US medical practices as assessed by an expert clinical panel.
    Weingart SN; Seger AC; Feola N; Heffernan J; Schiff G; Isaac T
    Drug Saf; 2011 Jul; 34(7):587-93. PubMed ID: 21663334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinician Perceptions of Timing and Presentation of Drug-Drug Interaction Alerts.
    Humphrey KE; Mirica M; Phansalkar S; Ozonoff A; Harper MB
    Appl Clin Inform; 2020 May; 11(3):487-496. PubMed ID: 32698231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing the value of electronic prescribing in ambulatory care: a focus group study.
    Weingart SN; Massagli M; Cyrulik A; Isaac T; Morway L; Sands DZ; Weissman JS
    Int J Med Inform; 2009 Sep; 78(9):571-8. PubMed ID: 19395307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turning off frequently overridden drug alerts: limited opportunities for doing it safely.
    van der Sijs H; Aarts J; van Gelder T; Berg M; Vulto A
    J Am Med Inform Assoc; 2008; 15(4):439-48. PubMed ID: 18436915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physicians' decisions to override computerized drug alerts in primary care.
    Weingart SN; Toth M; Sands DZ; Aronson MD; Davis RB; Phillips RS
    Arch Intern Med; 2003 Nov; 163(21):2625-31. PubMed ID: 14638563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation of a clinical decision support system for computerized drug prescription entries in a large tertiary care hospital.
    Zenziper Y; Kurnik D; Markovits N; Ziv A; Shamiss A; Halkin H; Loebstein R
    Isr Med Assoc J; 2014 May; 16(5):289-94. PubMed ID: 24979833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescriber response to computerized drug alerts for electronic prescriptions among hospitalized patients.
    Zenziper Straichman Y; Kurnik D; Matok I; Halkin H; Markovits N; Ziv A; Shamiss A; Loebstein R
    Int J Med Inform; 2017 Nov; 107():70-75. PubMed ID: 29029694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPs' views on computerized drug interaction alerts: questionnaire survey.
    Magnus D; Rodgers S; Avery AJ
    J Clin Pharm Ther; 2002 Oct; 27(5):377-82. PubMed ID: 12383140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of the effectiveness of interruptive medication prescribing alerts in hospital CPOE systems to change prescriber behavior and improve patient safety.
    Page N; Baysari MT; Westbrook JI
    Int J Med Inform; 2017 Sep; 105():22-30. PubMed ID: 28750908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary care physicians' challenges in ordering clinical laboratory tests and interpreting results.
    Hickner J; Thompson PJ; Wilkinson T; Epner P; Sheehan M; Pollock AM; Lee J; Duke CC; Jackson BR; Taylor JR
    J Am Board Fam Med; 2014; 27(2):268-74. PubMed ID: 24610189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.